Cargando…

Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway

Recurrence and metastasis are important features of osteosarcoma (OS) that cause its poor prognosis. Aberrant expression of Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) has been reported in various kinds of cancers. However, the expression and function of Siglec-15 in OS remain uncl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Meng-ke, Zhang, Guo-chuan, Chen, Wei, Qi, Li-li, Xie, Ming-fang, Zhang, Yue-yao, Wang, Ling, Zhang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322944/ https://www.ncbi.nlm.nih.gov/pubmed/34336699 http://dx.doi.org/10.3389/fonc.2021.710689

Ejemplares similares

Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis
por: Jiang, Kui-Ying, et al.
Publicado: (2023)

Siglec-15 as a New Perspective Therapy Target in Human Giant Cell Tumor of Bone
por: Fan, Mengke, et al.
Publicado: (2022)

Tumor Derived SIGLEC Family Genes May Play Roles in Tumor Genesis, Progression, and Immune Microenvironment Regulation
por: Chen, Zheng, et al.
Publicado: (2020)

Downregulation of DUSP9 Promotes Tumor Progression and Contributes to Poor Prognosis in Human Colorectal Cancer
por: Qiu, Zhaoyan, et al.
Publicado: (2020)

Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells via Deregulation of MAPK and Akt Signaling Pathway
por: Chen, Jiajia, et al.
Publicado: (2021)

DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma
por: Zhou, Fang, et al.
Publicado: (2023)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

Integrative Analysis of Siglec-15 mRNA in Human Cancers Based on Data Mining
por: Li, Qiu-ting, et al.
Publicado: (2020)

Corrigendum: Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells via Deregulation of MAPK and Akt Signaling Pathway
por: Chen, Jiajia, et al.
Publicado: (2021)

Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining
por: Zhang, Haiyan, et al.
Publicado: (2021)

Tumor stroma Siglec15 expression is a poor prognosis predictor in colon adenocarcinoma
por: Zhan, Weixiang, et al.
Publicado: (2023)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis
por: Liang, Haifeng, et al.
Publicado: (2022)

DUSP1 promotes muscle atrophy by inhibiting myocyte differentiation in cachectic patients
por: Sui, Xiangyu, et al.
Publicado: (2022)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
por: Hu, Xin, et al.
Publicado: (2022)

Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16
por: Liu, Wanshun, et al.
Publicado: (2021)

DUSP1 is involved in the progression of small cell carcinoma of the prostate
por: Zhang, Yajing, et al.
Publicado: (2018)

Investigating the Role of DUSP4 in Uveal Melanoma
por: Aughton, Karen, et al.
Publicado: (2022)

Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
por: Choi, Hyeree, et al.
Publicado: (2021)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma
por: Chen, Xianlong, et al.
Publicado: (2022)

CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
por: Cheng, Jun, et al.
Publicado: (2022)

DUSP5 and DUSP6 modulate corneal epithelial cell proliferation
por: Wang, Zheng, et al.
Publicado: (2010)

Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy
por: Liu, Xiaodi, et al.
Publicado: (2023)

The intriguing roles of Siglec family members in the tumor microenvironment
por: Jiang, Kui-Ying, et al.
Publicado: (2022)

The Updated Status and Future Direction of Immunotherapy Targeting B7-H1/PD-1 in Osteosarcoma
por: Fan, Meng-ke, et al.
Publicado: (2021)

A Novel Microfluidic Chip for Fast, Sensitive Quantification of Plasma Extracellular Vesicles as Biomarkers in Patients With Osteosarcoma
por: Xu, Yi-Qi, et al.
Publicado: (2021)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
por: Cagnoni, Alejandro J., et al.
Publicado: (2016)

A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?
por: Haas, Quentin, et al.
Publicado: (2018)

Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling
por: Jiang, Yafei, et al.
Publicado: (2021)

Siglec-15-induced autophagy promotes invasion and metastasis of human osteosarcoma cells by activating the epithelial–mesenchymal transition and Beclin-1/ATG14 pathway
por: Zheng, Bingxin, et al.
Publicado: (2022)

Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells
por: Li, Zhanzhan, et al.
Publicado: (2018)

Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression
por: Fan, Timothy M., et al.
Publicado: (2020)

Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
por: Yang, Jiali, et al.
Publicado: (2022)

DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers
por: Buffet, Camille, et al.
Publicado: (2017)

SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression
por: Goel, Swati, et al.
Publicado: (2021)

DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer
por: Teng, Fei, et al.
Publicado: (2018)

Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
por: Li, Baihui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8182ateukg85g3021g3rk06tj1